Oncolytics Biotech (ONCY) - 2024 Q1 - Quarterly Report

Oncolytics Biotech Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights ® Management hosting conference call and webcast today at 4:30 p.m. ET SAN DIEGO, CA and CALGARY, AB, March 7, 2024 -- Oncolytics Biotech Inc. (NASDAQ: ONCY) (TSX: ONC), a clinical-stage immunotherapeutics company focused on oncology, today announced recent operational highlights and financial results for the fourth quarter and year ended December 31, 2023. All dollar amounts are expressed in Canadian c ...